$EMCURE reported a 16.6% YoY rise in revenue to ₹9,204 crore for FY26, driven by international growth. PAT increased 33.1% to ₹941 crore, with EBITDA margins expanding 83 bps to 19.4%. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.